Chad Vezina

Benign urologic diseases (infection, increased voiding frequency, incontinence, bladder outlet obstruction) are associated with metabolic disease and diabetes. My current research examines mechanisms responsible for prostate-related urinary dysfunction in men, including sleep apnea, diabetes, and metabolic disease. I am actively involved in building new research model systems and tools for microscopic image analysis and urodynamic testing in rodent models. I have dedicated substantial effort to resolving the landscape of the prostate through molecular mapping studies as part of the NIH sponsored GenitoUrinary Development Molecular Anatomy Project (GUDMAP). I am also embedded in the urologic and toxicologic research fields, with roles in the Midwest Regional chapter of the Society of Toxicology, UW-Madison / UMASS Boston / UT Southwestern George M. O’Brien Center for Benign Urologic Research, and planning committee member for meetings of the Society of Toxicology, American Urological Society, and Society of Basic Urologic research.